InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,537.02
(
0.51%
)
US TECH 100
19,634.80
(
0.80%
)
Dow Jones
39,308.00
(
-0.06%
)
Brent Oil
86.84
(
-0.09%
)
Bitcoin
60,073.56
(
-0.15%
)
Post# of 252477
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 832
Posts 119978
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: dewophile post# 220207

Wednesday, 07/25/2018 8:34:44 PM

Wednesday, July 25, 2018 8:34:44 PM

Post# of 252477
Re: ApoE4+ proportion in each trial arm

See slide #20. For the placebo arm, the ApoE4+ proportion is 173/245=70.6%; for the 10mg/kg-biweekly arm, the ApoE4+ proportion is 48/161=29.8%.

p.s. The companies deliberately “hid” the ApoE4+ proportions by trial arm in a slide near the end of the deck that is ostensibly devoted to another topic (ARIA-E); this subterfuge is somewhat illuminating in its own right, IMO.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up